Ho, A. L., Kaur, V., Patel, S. A., Ferrarotto, R., Bowles, D. W., Li, Z., Chen, R., Murray, J., Pearson, A. T., Attarian, S., Zandberg, D. P., Kerrigan, K. C., Carducci, M. A. (2026). A phase 2 study of darolutamide plus leuprolide acetate in hormone therapy–naïve recurrent and/or metastatic androgen receptor (AR)–positive salivary gland cancer (ETCTN 10553).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6012